This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Clovis Oncology Inc (CLVS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 323.23M 144.10M 138.24M
Receivables 3.87M 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 659.00K 247.00K
Total Current Assets 328.60M 144.87M 141.52M
Property, Plant & Equipment, Gross 1.68M 1.59M 2.17M
Accumulated Depreciation & Depletion 728.00K 508.00K 274.00K
Property, Plant & Equipment, Net 955.00K 1.08M 1.90M
Intangibles 244.52M 0.00 0.00
Other Non-Current Assets 755.00K 38.00K 34.00K
Total Non-Current Assets 321.04M 1.12M 1.93M
Liabilities & Shareholder Equity
Total Assets 649.64M 145.99M 143.44M
Accounts Payable 4.42M 2.30M 3.04M
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00
Total Current Liabilities 20.95M 12.16M 11.00M
Long Term Debt 0.00 0.00 0.00
Deferred Income Taxes 74.96M 0.00 0.00
Other Non-Current Liabilities 55.84M 338.00K 656.00K
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 130.80M 338.00K 656.00K
Total Liabilities 151.75M 12.50M 11.65M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 497.89M 133.50M 131.79M
Common Par 34.00K 26.00K 22.00K
Additional Paid In Capital 762.17M 317.90M 242.22M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -269.01M -184.48M -110.50M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 4.70M 53.00K 49.00K
Total Capitalization 497.89M 133.50M 131.79M
Total Equity 497.89M 133.50M 131.79M
Total Liabilities & Stock Equity 649.64M 145.99M 143.44M
Total Common Shares Outstanding 33.90M 26.21M 22.38M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 28.67M 24.92M 3.85M
Diluted Weighted Shares Outstanding 28.67M 24.92M 3.85M
Number of Employees 74 61 57
Number of Part-Time Employees 0 0 0
CLVS News

CLVS Clovis Oncology Inc

Analysts Ratings for CLVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CLVS ANALYST REPORT

Brokerage Partners

CLVS Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs